Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06250088

Emdogain Adjunctive to Autotransplantation (ATTEMD)

Efficacy of Enamel Matrix Derivatives Adjunctive to Closed-apex Teeth Autotransplantation A Randomized Clinical Trial

Sponsor: Universidad Complutense de Madrid

Conditions Autologous Transplantation Autotransplantation Emdogain Enamel Matrix Derivatives

Interventions Emdogain (EMD) - test Sham group

Updated 4 times since 2024 Last updated: May 7, 2024 Started: Mar 12, 2024 Primary completion: Jun 1, 2025 Completion: Mar 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06250088, this PHASE4 trial focuses on Autologous Transplantation and Autotransplantation and remains actively recruiting participants. Sponsored by Universidad Complutense de Madrid, it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Mar 2024 — Jun 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Complutense de Madrid

Data source: Universidad Complutense de Madrid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain